| Message: | 1Estradiol Cypionate
CAS 313-06-4
Formula C26H36O3
Molecular Weight 396.62
EINECS 206-237-8
Assay 99%
Appearance White or off-white crystalline powder
Description:
Estrogens have been reported to increase the chance of womb (endometrial) cancer in women who have been through menopause, especially in women who receive estrogen-only hormone therapy. Estrogens may also increase the risk of cancer of the ovary or breast. Estrogen-containing products should not be used to prevent heart disease. Estrogen given with another hormone (progestin) for replacement therapy can infrequently cause heart disease (eg, heart attacks), stroke, serious blood clots in the legs or lungs (pulmonary embolism/deep vein thrombosis), dementia, and cancer of the breast. These risks appear to depend on the length of time estradiol cypionate is used and the amount of estrogen per dose. Therefore, estradiol cypionate should be used for the shortest possible length of time at the lowest effective dose so that you obtain the benefits and minimize the chance of serious side effects from long-term treatment. Consult your doctor or pharmacist for details.
|
my account
